The value of urotensin II in patients with left-sided rheumatic valvular regurgitation

Conclusion Urotensin II was elevated in patients with rheumatic left-sided valvular regurgitation, and positively correlated with increased LVEDD (in both MR and AR), LVESD (only AR) and pulmonary artery pressure (only MR). Therefore, urotensin II level may be used as diagnostic biomarker in patients with rheumatic valvular diseases for assessment of the severity in parallel with echocardiography.

Source: The Egyptian Heart Journal - October 10, 2016 Category: Cardiology Source Type: research